Merck & Co. Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study - PharmaLive (press release) (subscription)

Telegraph.co.uk

Merck & Co. Dealt Another Setback as Its Ace Keytruda Comes Up Short in Head and Neck Cancer Study PharmaLive (press release) (subscription) Head and neck cancer is a catch-all for various cancers that develop in or around the throat, larynx, nose, sinuses and mouth. The trial failure is the latest in setbacks for Keytruda. Earlier in July, the FDA placed a clinical hold on three clinical ... Merck Provides Update on Phase 3 Study of KEYTRUDA ...Business Wire (press release) all 11 news articles »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uxYDO0
via IFTTT